• FDA approves botox for spasticity

News & Views

FDA approves botox for spasticity

Mar 12 2010

Botox can now be used as a treatment for people suffering from spasticity following US Food and Drug Administration (FDA) approval.

Individuals who have tremors in their elbow, wrist and fingers could benefit from the decision, with the condition prevalent in those who have multiple sclerosis, brain injuries or have had a stroke.

Temporarily blocking signals between the nerves and muscles, botox is able to paralyse spastic limbs for a short-term period.

Director of the neurology products division of the FDA's centre for drug evaluation and research Russell Katz said it could help patients to cope with the condition more easily.

"Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living and may affect how a patient looks," he remarked.

According to the Multiple Sclerosis International Federation, more than two million people have the disease worldwide, with weak and unsteady limbs a common symptom.

Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events